1. Apoptosis
  2. TNF Receptor
  3. Certolizumab pegol

Certolizumab pegol  (Synonyms: 培塞利珠单抗; Certolizumab; CDP870)

目录号: HY-P9953 纯度: 99.30%
COA

Certolizumab pegol (Certolizumab) 是重组、聚乙二醇化、抗原结合片段的人源化单克隆抗体,可选择性靶向和中和肿瘤坏死因子-α (TNF-α)。 Certolizumab pegol 可用于类风湿关节炎和克罗恩病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CAS No. : 428863-50-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥1800
In-stock
5 mg ¥3800
In-stock
10 mg ¥6000
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research[1][2].

体外研究
(In Vitro)

Certolizumab pegol (Certolizumab) 中和可溶性 TNFα,IC90 为 3 ng/mL[2]
Certolizumab pegol (0-100 μg/mL,1 h) 完全抑制人单核细胞响应 LPS 产生的 IL-1β[2]
Certolizumab pegol 不介导补体依赖性细胞毒性 (CDC) 或抗体依赖性细胞介导的细胞毒性 (ADCC)[2]
Certolizumab pegol 不会诱导活化的人单核细胞或外周血淋巴细胞 (PBL) 的凋亡,也不会导致脱颗粒或丢失多形核细胞的细胞膜完整性[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Certolizumab pegol (Certolizumab) 中和可溶性 TNFα,IC90 为 3 ng/mL[2]
Certolizumab pegol (0-100 μg/mL,1 h) 完全抑制人单核细胞响应 LPS 产生的 IL-1β[2]
Certolizumab pegol 不介导补体依赖性细胞毒性 (CDC) 或抗体依赖性细胞介导的细胞毒性 (ADCC)[2]
Certolizumab pegol 不会诱导活化的人单核细胞或外周血淋巴细胞 (PBL) 的凋亡,也不会导致脱颗粒或丢失多形核细胞的细胞膜完整性[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Healthy Wistar Albino male rats weighing 180 to 200 g, acute edematous pancreatitis was induced via intraperitoneal injection of 80 μg/kg Cerulein (HY-A0190) (20 μg/kg, 4 times at 1-hour intervals)[3]
Dosage: 10 μg
Administration: Intraperitoneal administration, single dose
Result: Significantly decreased the serum levels of amylase, lipase, and lactate dehydrogenase. Histopathological edema, hemorrhage, parenchymal necrosis, and infiltration scores were also decreased, along with a decrease in malondialdehyde, myeloperoxidase, TNF-α, and caspase-3 activities.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

赛妥珠单抗; 培塞利珠单抗

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Format
  • Fab'-G1-kappa
纯度 & 产品资料

纯度: 99.30%

参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Certolizumab pegol
目录号:
HY-P9953
需求量: